IP Consulting Group

🚨 Major Legal Twist in the Automotive Software Industry 🚨

A U.S. appeals court has revived $82.2 million of a verdict against Ford in a high-profile trade secrets and licensing dispute with Versata Software.

The Federal Circuit reinstated damages awarded by a Detroit jury after finding that Ford breached its software licensing agreement with Versata. The case will now return for a new trial to determine the appropriate damages related to trade-secret misappropriation.

📌 Key Highlights:
🔹 Original jury verdict totaled $104.6 million
🔹 $82.2 million restored for breach of contract
🔹 New trial ordered for trade-secret damages
🔹 Case centers around automotive collaboration software used globally by Ford

The ruling highlights the growing importance of:
✔️ Trade secret protection
✔️ Software licensing compliance
✔️ Strong contractual enforcement
✔️ IP governance in the automotive and tech sectors

As digital transformation accelerates across industries, intellectual property disputes involving software and proprietary systems are becoming increasingly critical.

📌 𝐂𝐨𝐧𝐭𝐚𝐜𝐭 IP Consulting Group 𝐅𝐨𝐫 𝐚 𝐅𝐫𝐞𝐞 𝐭𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐈𝐏 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐥𝐞𝐠𝐚𝐥 𝐠𝐮𝐢𝐝𝐚𝐧𝐜𝐞:
📧 [email protected]
🌐 www.ipconsultinggroups.com
📞 DC: +1 (202) 666-8377 | MD: +1 (240) 477-6361

💊 Roche & Medicines Patent Pool Join Forces to Expand Global Access to Influenza Treatment 🌍

Swiss pharmaceutical giant Roche and Medicines Patent Pool have signed a landmark licensing agreement to improve access to the influenza antiviral drug Xofluza across 129 low- and middle-income countries.

The agreement will allow generic manufacturers to develop, manufacture, and distribute affordable versions of the treatment, helping strengthen preparedness for seasonal flu outbreaks and future pandemics.

🔹 Key Highlights:
✔️ Access expanded across 129 countries
✔️ Generic manufacturers invited to produce the drug under license
✔️ Supports faster development with regulatory and technical assistance
✔️ Helps improve global pandemic preparedness
✔️ WHO-recommended treatment for influenza

Xofluza has shown effectiveness against certain flu strains resistant to older antiviral drugs, making it an important tool in global outbreak management.

According to Medicines Patent Pool Executive Director Charles Gore, the agreement aims to ensure treatment tools and manufacturing capacity are available before the next global health emergency.

📌 This collaboration highlights the growing importance of patent licensing and global partnerships in improving equitable healthcare access worldwide.

📌 𝐂𝐨𝐧𝐭𝐚𝐜𝐭 IP Consulting Group 𝐅𝐨𝐫 𝐚 𝐅𝐫𝐞𝐞 𝐭𝐚𝐢𝐥𝐨𝐫𝐞𝐝 𝐈𝐏 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐥𝐞𝐠𝐚𝐥 𝐠𝐮𝐢𝐝𝐚𝐧𝐜𝐞:
📧 [email protected]
🌐 www.ipconsultinggroups.com
📞 DC: +1 (202) 666-8377 | MD: +1 (240) 477-6361